$HQY
HEALTHEQUITY, INC. Stock $hqy

$hqy Overview Financials Valuation SEC Filings Company Website

2016 Q2 Form 10-Q Financial Statement

#000142833616000048 Filed on June 09, 2016

Income Statement

Concept	2016 Q2	2015 Q2
Revenue	$44.01M	$29.85M
YoY Change	47.45%	47.55%
Cost Of Revenue	$16.33M	$11.94M
YoY Change	36.74%	36.16%
Gross Profit	$27.68M	$17.91M
YoY Change	54.59%	56.26%
Gross Profit Margin	62.89%	59.99%
Selling, General & Admin	$8.757M	$5.991M
YoY Change	46.17%	77.46%
% of Gross Profit	31.64%	33.46%
Research & Development	$4.625M	$3.524M
YoY Change	31.24%	61.21%
% of Gross Profit	16.71%	19.68%
Depreciation & Amortization	$2.947M	$1.750M
YoY Change	68.4%	39.89%
% of Gross Profit	10.65%	9.77%
Operating Expenses	$14.43M	$9.924M
YoY Change	45.42%	66.2%
Operating Profit	$13.25M	$7.982M
YoY Change	66.0%	45.44%
Interest Expense		$0.00
YoY Change		-100.0%
% of Operating Profit		0.0%
Other Income/Expense, Net	-$641.0K	-$105.0K
YoY Change	510.48%	-87.3%
Pretax Income	$12.61M	$7.877M
YoY Change	60.07%	69.0%
Income Tax	$4.536M	$2.900M
% Of Pretax Income	35.97%	36.82%
Net Earnings	$8.073M	$4.977M
YoY Change	62.21%	83.11%
Net Earnings / Revenue	18.34%	16.67%
Basic Earnings Per Share	$0.14	$0.09
Diluted Earnings Per Share	$0.14	$0.09
COMMON SHARES
Basic Shares Outstanding	57.82M shares	55.06M shares
Diluted Shares Outstanding	59.40M shares	57.77M shares

Balance Sheet

Concept	2016 Q2	2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$132.9M	$114.9M
YoY Change	15.67%	720.71%
Cash & Equivalents	$92.77M	$74.86M
Short-Term Investments	$40.20M	$40.00M
Other Short-Term Assets	$6.300M	$4.200M
YoY Change	50.0%	31.25%
Inventory	$598.0K	$667.0K
Prepaid Expenses	$6.300M	$2.761M
Receivables	$15.71M	$10.48M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$155.5M	$130.3M
YoY Change	19.39%	452.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.388M	$3.079M
YoY Change	10.04%	39.95%
Goodwill	$4.651M	$4.651M
YoY Change	0.0%
Intangibles	$66.45M	$26.62M
YoY Change	149.66%
Long-Term Investments	$281.0K	$300.0K
YoY Change	-6.33%
Other Assets	$1.874M	$662.0K
YoY Change	183.08%
Total Long-Term Assets	$76.71M	$35.01M
YoY Change	119.11%	8.39%
TOTAL ASSETS
Total Short-Term Assets	$155.5M	$130.3M
Total Long-Term Assets	$76.71M	$35.01M
Total Assets	$232.2M	$165.3M
YoY Change	40.51%	195.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.226M	$990.0K
YoY Change	23.84%	41.43%
Accrued Expenses	$3.146M	$2.153M
YoY Change	46.12%	-47.49%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$6.975M	$5.184M
YoY Change	34.55%	-10.62%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$800.0K	$500.0K
YoY Change	60.0%	25.0%
Total Long-Term Liabilities	$2.530M	$5.530M
YoY Change	-54.25%	1282.5%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.975M	$5.184M
Total Long-Term Liabilities	$2.530M	$5.530M
Total Liabilities	$9.505M	$10.71M
YoY Change	-11.28%	-7.64%
SHAREHOLDERS EQUITY
Retained Earnings	$11.68M	-$8.027M
YoY Change	-245.53%
Common Stock	$6.000K	$6.000K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$222.7M	$154.6M
YoY Change
Total Liabilities & Shareholders Equity	$232.2M	$165.3M
YoY Change	40.51%	195.67%

Cashflow Statement

Concept	2016 Q2	2015 Q2
OPERATING ACTIVITIES
Net Income	$8.073M	$4.977M
YoY Change	62.21%	83.11%
Depreciation, Depletion And Amortization	$2.947M	$1.750M
YoY Change	68.4%	39.89%
Cash From Operating Activities	$2.112M	$1.771M
YoY Change	19.25%	21.05%
INVESTING ACTIVITIES
Capital Expenditures	$321.0K	$826.0K
YoY Change	-61.14%	72.08%
Acquisitions
YoY Change
Other Investing Activities	-$100.0K	-$40.10M
YoY Change	-99.75%
Cash From Investing Activities	-$2.410M	-$42.34M
YoY Change	-94.31%	1831.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$9.423M	$4.424M
YoY Change	113.0%	451.62%
NET CHANGE
Cash From Operating Activities	$2.112M	$1.771M
Cash From Investing Activities	-$2.410M	-$42.34M
Cash From Financing Activities	$9.423M	$4.424M
Net Change In Cash	$9.125M	-$36.14M
YoY Change	-125.25%	-49612.33%
FREE CASH FLOW
Cash From Operating Activities	$2.112M	$1.771M
Capital Expenditures	$321.0K	$826.0K
Free Cash Flow	$1.791M	$945.0K
YoY Change	89.52%	-3.87%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q2	dei	Amendment Flag AmendmentFlag	false
CY2016Q2	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-31
CY2016Q2	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2016Q2	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2016Q2	dei	Document Period End Date DocumentPeriodEndDate	2016-04-30
CY2016Q2	dei	Document Type DocumentType	10-Q
CY2016Q2	dei	Entity Central Index Key EntityCentralIndexKey	0001428336
CY2016Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	58087307	shares
CY2016Q2	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2016Q2	dei	Entity Registrant Name EntityRegistrantName	HEALTHEQUITY INC
CY2015Q2	hqy	Amortizationof Acquired Intangible AmortizationofAcquiredIntangible	409000	USD
CY2016Q2	hqy	Amortizationof Acquired Intangible AmortizationofAcquiredIntangible	1049000	USD
CY2016Q1	hqy	Cash Cash Equivalentsand Shortterm Investments Fair Value Disclosure CashCashEquivalentsandShorttermInvestmentsFairValueDisclosure	123775000	USD
CY2016Q2	hqy	Cash Cash Equivalentsand Shortterm Investments Fair Value Disclosure CashCashEquivalentsandShorttermInvestmentsFairValueDisclosure	132925000	USD
CY2016Q2	hqy	Cost Method Investment Ownership Percentage CostMethodInvestmentOwnershipPercentage	0.02
CY2015Q2	hqy	Cost Of Services Card Costs CostOfServicesCardCosts	2102000	USD
CY2016Q2	hqy	Cost Of Services Card Costs CostOfServicesCardCosts	2719000	USD
CY2015Q2	hqy	Cost Of Services Custodial Costs CostOfServicesCustodialCosts	1423000	USD
CY2016Q2	hqy	Cost Of Services Custodial Costs CostOfServicesCustodialCosts	2356000	USD
CY2016Q2	hqy	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost Excess Stock Option Benefits Previously Not Recognized DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCostExcessStockOptionBenefitsPreviouslyNotRecognized	7400000	USD
CY2015Q2	hqy	Other Expenses Agreements OtherExpensesAgreements	60000	USD
CY2016Q2	hqy	Other Expenses Agreements OtherExpensesAgreements	60000	USD
CY2016Q2	hqy	Sharebased Compensation Shares Authorizedunder Stock Option Plans Exercise Price Range Lower Range Limit Exercised SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised	0.10
CY2016Q2	hqy	Sharebased Compensation Shares Authorizedunder Stock Option Plans Exercise Price Range Lower Range Limit Forfeited SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited	3.50
CY2016Q2	hqy	Sharebased Compensation Shares Authorizedunder Stock Option Plans Exercise Price Range Lower Range Limit Granted SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeLowerRangeLimitGranted	21.27
CY2016Q1	hqy	Sharebased Compensation Shares Authorizedunder Stock Option Plans Exercise Price Range Lower Range Limit Outstanding SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding	0.10
CY2016Q2	hqy	Sharebased Compensation Shares Authorizedunder Stock Option Plans Exercise Price Range Lower Range Limit Outstanding SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding	0.10
CY2016Q2	hqy	Sharebased Compensation Shares Authorizedunder Stock Option Plans Exercise Price Range Upper Range Limit Exercised SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised	22.45
CY2016Q2	hqy	Sharebased Compensation Shares Authorizedunder Stock Option Plans Exercise Price Range Upper Range Limit Forfeited SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited	28.69
CY2016Q2	hqy	Sharebased Compensation Shares Authorizedunder Stock Option Plans Exercise Price Range Upper Range Limit Granted SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeUpperRangeLimitGranted	24.36
CY2016Q1	hqy	Sharebased Compensation Shares Authorizedunder Stock Option Plans Exercise Price Range Upper Range Limit Outstanding SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding	33.47
CY2016Q2	hqy	Sharebased Compensation Shares Authorizedunder Stock Option Plans Exercise Price Range Upper Range Limit Outstanding SharebasedCompensationSharesAuthorizedunderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding	33.47
CY2016Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2431000	USD
CY2016Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1226000	USD
CY2016Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	14308000	USD
CY2016Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15706000	USD
CY2016Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1899000	USD
CY2016Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3146000	USD
CY2016Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4611000	USD
CY2016Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5058000	USD
CY2016Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-98000	USD
CY2016Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-137000	USD
CY2016Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	199940000	USD
CY2016Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	211185000	USD
CY2015Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1094000	USD
CY2016Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1822000	USD
CY2016Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	40000	USD
CY2016Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	36000	USD
CY2015Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
CY2016Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	18000	USD
CY2015Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1400000	USD
CY2016Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2500000	USD
CY2015Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	679000	shares
CY2016Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1600000	shares
CY2016Q1	us-gaap	Assets Assets	219795000	USD
CY2016Q2	us-gaap	Assets Assets	232241000	USD
CY2016Q1	us-gaap	Assets Current AssetsCurrent	143048000	USD
CY2016Q2	us-gaap	Assets Current AssetsCurrent	155529000	USD
CY2016Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	40134000	USD
CY2016Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	40159000	USD
CY2016Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	78000	USD
CY2016Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	104000	USD
CY2016Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	236000	USD
CY2016Q2	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	323000	USD
CY2016Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	15199000	USD
CY2016Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	15000000	USD
CY2016Q2	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	40159000	USD
CY2016Q2	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	40378000	USD
CY2016Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	25179000	USD
CY2016Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	25159000	USD
CY2015Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
CY2016Q2	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	8000	USD
CY2015Q2	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	1200000	USD
CY2016Q2	us-gaap	Capitalized Computer Software Additions CapitalizedComputerSoftwareAdditions	1900000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	111005000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	74861000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	83641000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	92766000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	83641000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	92766000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-36144000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	9125000	USD
CY2016Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	123933000	USD
CY2016Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	133144000	USD
CY2016Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2016Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2016Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57726000	shares
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57945000	shares
CY2016Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	57726000	shares
CY2016Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	57945000	shares
CY2016Q1	us-gaap	Common Stock Value CommonStockValue	6000	USD
CY2016Q2	us-gaap	Common Stock Value CommonStockValue	6000	USD
CY2016Q2	us-gaap	Cost Method Investments CostMethodInvestments	500000	USD
CY2015Q2	us-gaap	Cost Of Services CostOfServices	11944000	USD
CY2016Q2	us-gaap	Cost Of Services CostOfServices	16332000	USD
CY2015Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2000	USD
CY2016Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	34000	USD
CY2016Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	236000	USD
CY2016Q2	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	819000	USD
CY2016Q1	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	2642000	USD
CY2016Q2	us-gaap	Deferred Tax Assets Liabilities Net Current DeferredTaxAssetsLiabilitiesNetCurrent	0	USD
CY2016Q1	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	0	USD
CY2016Q2	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	345000	USD
CY2016Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	9300000	USD
CY2016Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	3996000	USD
CY2016Q2	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	1711000	USD
CY2015Q2	us-gaap	Depreciation Depreciation	324000	USD
CY2016Q2	us-gaap	Depreciation Depreciation	447000	USD
CY2015Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1750000	USD
CY2016Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2947000	USD
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2015Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.368
CY2016Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.360
CY2016Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7776000	USD
CY2016Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2603000	USD
CY2016Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y7M
CY2016Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	15600000	USD
CY2016Q2	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.22
CY2016Q2	us-gaap	Equity Method Investments EquityMethodInvestments	281000	USD
CY2015Q2	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	3931000	USD
CY2016Q2	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	9278000	USD
CY2015Q2	us-gaap	Fees And Commissions Credit And Debit Cards FeesAndCommissionsCreditAndDebitCards	6817000	USD
CY2016Q2	us-gaap	Fees And Commissions Credit And Debit Cards FeesAndCommissionsCreditAndDebitCards	11208000	USD
CY2016Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	20206000	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	22706000	USD
CY2016Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	87046000	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	89160000	USD
CY2016Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	66840000	USD
CY2016Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	66454000	USD
CY2015Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3158000	USD
CY2016Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4574000	USD
CY2016Q1	us-gaap	Goodwill Goodwill	4651000	USD
CY2016Q2	us-gaap	Goodwill Goodwill	4651000	USD
CY2015Q2	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	USD
CY2016Q2	us-gaap	Goodwill Period Increase Decrease GoodwillPeriodIncreaseDecrease	0	USD
CY2015Q2	us-gaap	Gross Profit GrossProfit	17906000	USD
CY2016Q2	us-gaap	Gross Profit GrossProfit	27681000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7877000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	12609000	USD
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2900000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4536000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4500000	USD
CY2015Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-340000	USD
CY2016Q2	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1241000	USD
CY2015Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1425000	USD
CY2016Q2	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1398000	USD
CY2015Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-99000	USD
CY2016Q2	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1164000	USD
CY2015Q2	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-3260000	USD
CY2016Q2	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-5173000	USD
CY2015Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	42000	USD
CY2016Q2	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-22000	USD
CY2015Q2	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-11000	USD
CY2016Q2	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	583000	USD
CY2015Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	871000	USD
CY2016Q2	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	4739000	USD
CY2015Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2707000	shares
CY2016Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1579000	shares
CY2016Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	66840000	USD
CY2016Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	66454000	USD
CY2016Q1	us-gaap	Inventory Net InventoryNet	620000	USD
CY2016Q2	us-gaap	Inventory Net InventoryNet	598000	USD
CY2015Q2	us-gaap	Investment Advisory Management And Administrative Fees InvestmentAdvisoryManagementAndAdministrativeFees	8419000	USD
CY2016Q2	us-gaap	Investment Advisory Management And Administrative Fees InvestmentAdvisoryManagementAndAdministrativeFees	13811000	USD
CY2015Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	464000	USD
CY2016Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	593000	USD
CY2016Q1	us-gaap	Liabilities Liabilities	16338000	USD
CY2016Q2	us-gaap	Liabilities Liabilities	9505000	USD
CY2016Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	219795000	USD
CY2016Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	232241000	USD
CY2016Q1	us-gaap	Liabilities Current LiabilitiesCurrent	12106000	USD
CY2016Q2	us-gaap	Liabilities Current LiabilitiesCurrent	6975000	USD
CY2016Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	4232000	USD
CY2016Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2530000	USD
CY2015Q2	us-gaap	Membership Dues Revenue On Going MembershipDuesRevenueOnGoing	14614000	USD
CY2016Q2	us-gaap	Membership Dues Revenue On Going MembershipDuesRevenueOnGoing	18994000	USD
CY2015Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4424000	USD
CY2016Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9423000	USD
CY2015Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-42339000	USD
CY2016Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2410000	USD
CY2015Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1771000	USD
CY2016Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2112000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	4977000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	8073000	USD
CY2015Q2	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1		USD
CY2016Q2	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	111000	USD
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	9924000	USD
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	14431000	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	7982000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	13250000	USD
CY2016Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1750000	USD
CY2016Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1874000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-22000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-39000	USD
CY2015Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	4955000	USD
CY2016Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	8034000	USD
CY2015Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	105000	USD
CY2016Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	641000	USD
CY2015Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-105000	USD
CY2016Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-641000	USD
CY2015Q2	us-gaap	Payments For Software PaymentsForSoftware	1451000	USD
CY2016Q2	us-gaap	Payments For Software PaymentsForSoftware	2003000	USD
CY2015Q2	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	40062000	USD
CY2016Q2	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	86000	USD
CY2015Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	826000	USD
CY2016Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	321000	USD
CY2016Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2016Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2016Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2016Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2016Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1703000	USD
CY2016Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	6300000	USD
CY2015Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	493000	USD
CY2016Q2	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	145000	USD
CY2016Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8117000	USD
CY2016Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	8446000	USD
CY2016Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3506000	USD
CY2016Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3388000	USD
CY2015Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3524000	USD
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4625000	USD
CY2015Q2	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	1700000	USD
CY2016Q2	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	2100000	USD
CY2016Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3609000	USD
CY2016Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	11682000	USD
CY2015Q2	us-gaap	Revenues Revenues	29850000	USD
CY2016Q2	us-gaap	Revenues Revenues	44013000	USD
CY2015Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2833000	USD
CY2016Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4183000	USD
CY2015Q2	us-gaap	Service Management Costs ServiceManagementCosts	8419000	USD
CY2016Q2	us-gaap	Service Management Costs ServiceManagementCosts	11257000	USD
CY2015Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1094000	USD
CY2016Q2	us-gaap	Share Based Compensation ShareBasedCompensation	1822000	USD
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.4029
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.3837
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.3829
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0164
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0152
CY2015Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0147
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0133
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.65
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	21.09
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	52000	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	842000	shares
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	63965000	USD
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	75056000	USD
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5418000	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5990000	shares
CY2016Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	10.88
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	13.01
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	73737000	USD
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	2591000	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	5753000	shares
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	12.71
CY2016Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.67
CY2016Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	23.97
CY2016Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	53180000	USD
CY2016Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y6M0D
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y0M11D
CY2016Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y4M18D
CY2016Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y3M23D
CY2016Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	218000	shares
CY2016Q1	us-gaap	Stockholders Equity StockholdersEquity	203457000	USD
CY2016Q2	us-gaap	Stockholders Equity StockholdersEquity	222736000	USD
CY2016Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	393000	USD
CY2016Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	448000	USD
CY2016Q2	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	369000	USD
CY2015Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57770000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59399000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55063000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57820000	shares

Files In Submission

Name	View Source	Status
0001428336-16-000048-index-headers.html	Edgar Link	pending
0001428336-16-000048-index.html	Edgar Link	pending
0001428336-16-000048.txt	Edgar Link	pending
0001428336-16-000048-xbrl.zip	Edgar Link	pending
exhibit101-amendedandresta.htm	Edgar Link	pending
exhibit3112016-04x30.htm	Edgar Link	pending
exhibit3122016-04x30.htm	Edgar Link	pending
exhibit3212016-04x30.htm	Edgar Link	pending
exhibit3222016-04x30.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
hqy-20160430.xml	Edgar Link	completed
hqy-20160430.xsd	Edgar Link	pending
hqy-20160430_cal.xml	Edgar Link	unprocessable
hqy-20160430_def.xml	Edgar Link	unprocessable
hqy-20160430_lab.xml	Edgar Link	unprocessable
hqy-20160430_pre.xml	Edgar Link	unprocessable
hqy-2016x04x3010q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HQY
HEALTHEQUITY, INC. Stock $hqy

2016 Q2 Form 10-Q Financial Statement

#000142833616000048 Filed on June 09, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HQY HEALTHEQUITY, INC. Stock $hqy

2016 Q2 Form 10-Q Financial Statement

#000142833616000048 Filed on June 09, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HQY
HEALTHEQUITY, INC. Stock $hqy